Asset Management Ventures

SeeQC, Inc. is a semiconductor company specializing in the development of a digital quantum computing platform aimed at global businesses. Founded in 2018 and headquartered in Elmsford, New York, the company designs, tests, and manufactures quantum-ready superconductors and application-specific quantum computing systems. Its innovative approach combines classical and quantum technologies to enhance the efficiency, stability, and cost-effectiveness of quantum computing systems. SeeQC integrates superconducting qubit chips, proprietary Single Flux Quantum technology, and application-specific integrated circuits to create a commercially viable quantum computing solution. The company serves various industries, including machine learning, logistics optimization, quantum chemistry, pharmaceuticals, and fintech, catering to clients in the United States and Europe. With additional facilities in London and Naples, SeeQC aims to facilitate access to scalable, fault-tolerant quantum computing applications, thereby addressing the growing demand for advanced computational capabilities.

Medsien is a provider of remote care management services that utilizes artificial intelligence to enhance patient engagement and health outcomes. The company has developed a platform that integrates various care management programs, allowing healthcare providers to efficiently monitor chronic conditions and manage remote patient care. By curating and aggregating patient data, Medsien's technology delivers insights into patient health trends and metrics, enabling real-time notifications of any changes. This streamlined approach not only improves the patient experience but also helps reduce costs and supports informed decision-making for healthcare providers.

Endless Health is a company focused on cardiovascular health, providing individuals with a comprehensive platform for heart disease prevention and management. It offers research-backed information about heart conditions and facilitates connections with certified healthcare professionals through video chat and messaging. The company emphasizes early detection and personalized intervention strategies, integrating technology with medical expertise to enhance accessibility and accuracy in heart health management. Users can track their health data and behaviors through a single dashboard, which promotes accountability and empowers individuals to take control of their cardiovascular health journey. By enabling proactive management, Endless Health aims to reduce the risk of cardiovascular diseases.

Basys.ai is a technology company focused on automating prior authorization and utilization management processes for health plans and payers. Utilizing a proprietary AI-based platform, Basys.ai streamlines the encoding and digitization of payer policies through machine learning, significantly reducing the time needed for implementation. The platform enhances communication between patients and healthcare providers, integrates electronic health records, and employs algorithms aimed at improving care quality. By facilitating these processes, Basys.ai helps health plans lower administrative and medical costs while enabling organizations to effectively monitor patient health records and optimize patient outcomes.

Autonomize AI is a leader in the AI-driven healthcare sector, dedicated to transforming the industry through the development of advanced AI copilots. These copilots are designed to organize, contextualize, and summarize unstructured data, thereby alleviating the administrative burdens faced by healthcare knowledge workers. This functionality allows professionals to make swift, data-driven decisions that enhance patient outcomes. Autonomize AI's solutions encompass various applications, including clinical trials, target discovery, drug toxicity, commercial intelligence, and patient journeys, enabling healthcare professionals to efficiently extract contextual information from diverse healthcare data sources. As a founding member of CancerX, part of the US President Biden's Cancer Moonshot initiative, the company is committed to innovation in cancer research and treatment. Its clientele includes top pharmaceutical companies, major payors, and leading firms in life sciences, reflecting its significant impact on the healthcare landscape through the use of natural language processing, machine learning, and advanced data analytics.

SubjectWell is a clinical trial marketplace focused on patient recruitment, providing a risk-free platform for healthcare clients to efficiently find and screen qualified participants for clinical trials. By streamlining the recruitment process, SubjectWell helps accelerate the completion of studies, ensuring that healthcare organizations can meet their research timelines effectively. The company specializes in delivering highly qualified referrals, thereby enhancing the overall efficiency of clinical trials and contributing to advancements in medical research.

Array Insights is an IT firm focused on developing artificial intelligence-driven solutions aimed at managing patient and caregiver narratives. The company offers a clinical data registry platform that enables the secure sharing of sensitive healthcare data while maintaining ownership and compliance. By employing advanced encryption techniques, Array Insights connects data algorithms to facilitate the analysis and training of AI models without compromising security or privacy. This platform allows hospitals and healthcare providers to effectively control, track, and trace patient information, thereby enhancing research capabilities and accelerating the pace of innovation in the healthcare sector. Founded in 2017 and based in Cambridge, Massachusetts, Array Insights is dedicated to improving data accessibility while safeguarding proprietary and sensitive information.

Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.

LegalMate is a business focused on improving access to legal services for individuals, particularly those from low-income backgrounds. Recognizing that a significant number of civil legal problems go unresolved due to inadequate representation, LegalMate offers a financing solution that allows law firms to receive their fees upfront, while adhering to regulatory guidelines. This model not only alleviates the financial burden on clients but also empowers them to seek legal assistance on their own terms. In addition to its financing services, LegalMate has developed a legal automation platform designed to streamline workflow and tailor solutions to the specific needs of clients. By automating complex legal processes, the platform enhances efficiency for law firms and legal professionals, enabling them to devote more time to delivering high-quality legal services.

Pluto Health is a technology company that specializes in consumer health applications designed to improve patient care through enhanced data integration and communication. The platform aggregates information from electronic health records, pharmacies, laboratories, and insurance claims, enabling patients to access a comprehensive view of their health data. By automating insights and reminders for tasks such as medication tracking and bill payments, Pluto Health empowers users to take an active role in their healthcare. The company also focuses on identifying and addressing gaps in care by creating personalized care plans tailored to individual health needs. By facilitating better coordination among healthcare providers and patients, Pluto Health aims to enhance preventive care and improve access to essential medical resources, including clinical trials.

Outcomes4me Inc. is a healthcare technology company based in Cambridge, Massachusetts, founded in 2017. It has developed an AI-driven patient empowerment platform specifically designed for cancer patients, enabling them to take a proactive approach in managing their care. The platform provides personalized, evidence-based treatment options and real-time clinical information, facilitating informed decision-making and improving patient outcomes. By connecting patients with healthcare providers and offering resources related to breast cancer treatment and clinical trials, Outcomes4me aims to democratize healthcare and promote health equity. The company is led by a team of experienced professionals from healthcare, oncology, pharmaceuticals, and technology sectors, dedicated to generating insights that enhance care and accelerate research and access to innovative treatments.

Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.

Array Insights is an IT firm focused on developing artificial intelligence-driven solutions aimed at managing patient and caregiver narratives. The company offers a clinical data registry platform that enables the secure sharing of sensitive healthcare data while maintaining ownership and compliance. By employing advanced encryption techniques, Array Insights connects data algorithms to facilitate the analysis and training of AI models without compromising security or privacy. This platform allows hospitals and healthcare providers to effectively control, track, and trace patient information, thereby enhancing research capabilities and accelerating the pace of innovation in the healthcare sector. Founded in 2017 and based in Cambridge, Massachusetts, Array Insights is dedicated to improving data accessibility while safeguarding proprietary and sensitive information.

Outcomes4me Inc. is a healthcare technology company based in Cambridge, Massachusetts, founded in 2017. It has developed an AI-driven patient empowerment platform specifically designed for cancer patients, enabling them to take a proactive approach in managing their care. The platform provides personalized, evidence-based treatment options and real-time clinical information, facilitating informed decision-making and improving patient outcomes. By connecting patients with healthcare providers and offering resources related to breast cancer treatment and clinical trials, Outcomes4me aims to democratize healthcare and promote health equity. The company is led by a team of experienced professionals from healthcare, oncology, pharmaceuticals, and technology sectors, dedicated to generating insights that enhance care and accelerate research and access to innovative treatments.

Lark is a developer of a virtual platform focused on chronic disease prevention and management. Founded in 2011 by Julia Hu and Jeff Zira, the company is headquartered in Mountain View, California. Lark's platform leverages advanced artificial intelligence alongside human coaching and connected devices to offer real-time, personalized support and counseling. This approach aims to help users make healthier choices and effectively manage their chronic conditions. The company's programs, including those recognized by the CDC for diabetes prevention, wellness, diabetes care, and hypertension, serve approximately 1.5 million users. These initiatives have shown clinically validated improvements in health outcomes, as documented in multiple peer-reviewed journals and analyst reports.

Reify Health, Inc. is a Baltimore-based company that specializes in cloud-based software aimed at enhancing the development of new therapies within the life sciences sector. Founded in 2010, Reify Health provides solutions designed to streamline clinical research processes, particularly in the area of patient enrollment for clinical trials. Its flagship product, StudyTeam, allows research sponsors, contract research organizations, and clinical sites to achieve faster and more predictable enrollment outcomes. By automating and simplifying the enrollment process, Reify Health's software enables teams to concentrate on essential tasks that drive research success, thereby improving overall productivity and optimizing study budgets.

Unnatural Products Inc. is a biotechnology company based in Santa Cruz, California, focused on drug discovery through innovative technology. Founded in 2016, the company specializes in designing and developing a platform that utilizes artificial intelligence and computational biology techniques to create macrocyclic peptides. These peptides target intracellular protein interactions, addressing drug targets that are typically considered undruggable. By harnessing machine learning to optimize chemical synthesis, Unnatural Products aims to accelerate the drug discovery process, offering potential therapeutic strategies for a wide range of medical conditions. Through its unique approach, the company seeks to pioneer new treatments where traditional methods have fallen short.

Aegis Surgical Limited will facilitate less invasive placement of aortic valves compared to open heart surgery, on an out-patient basis.

Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.

UniKey Technologies, Inc. is a provider of innovative access control solutions, specializing in smart locking technologies for residential, commercial, and hospitality applications. Founded in 2010 and headquartered in Winter Park, Florida, the company transforms smartphones into universal electronic keys, allowing users to unlock doors with a simple touch while keeping their devices in pockets or purses. UniKey's patented technology includes features that can assess whether an authorized user is inside or outside a property before granting access, enhancing security and preventing unauthorized entry. The company collaborates with prominent lock manufacturers like Kwikset and Weiser to develop smart locks, notably the Kevo system, and offers a cloud-based lock management solution tailored for multifamily properties and commercial businesses. By delivering advanced smart lock and access control technologies, UniKey addresses a wide range of security needs.

Welkin Health, Inc. is a San Francisco-based company that develops and operates a cloud-based patient management software platform. Founded in 2013, the platform is designed to enhance care delivery by guiding healthcare teams through workflows that ensure patients receive timely and appropriate care. It allows health workers to focus on patients who need attention at critical moments, fostering meaningful relationships between providers and patients. The software is customizable and scalable, supporting a wide range of care programs, including those for chronic diseases and various specialties such as mental health, substance abuse, and oncology. Welkin Health also facilitates communication between health plans, providers, and patients through multiple channels, including phone, text, video, and email, thereby enabling more effective engagement and streamlined care processes.

Mightier is a Boston-based gaming platform established in 2016 that focuses on helping children develop emotional regulation skills through bioresponsive video games. The company's innovative program, developed in collaboration with Boston Children's Hospital and Harvard Medical School, utilizes a heart rate monitor to create a unique gaming experience where the game's difficulty adjusts based on the player's emotional state. This approach allows children to visualize their emotions in real-time, enabling them to learn how to manage their feelings effectively. By engaging with these games, kids with behavioral and emotional challenges can discover their emotional strengths and improve their ability to cope with daily situations.

Signal Vine, Inc. is a technology company that specializes in developing an enterprise text messaging platform designed to enhance communication within educational and nonprofit sectors. Founded in 2013 and headquartered in Alexandria, Virginia, the company offers a range of features including targeted messaging, an intuitive interface, case management, and comprehensive reporting and analytics. By utilizing a blended messaging approach, Signal Vine enables its clients—such as K-12 schools, higher education institutions, nonprofits, and government programs—to leverage student data to deliver personalized communications. This capability aims to improve student engagement by sending timely reminders and support messages about important deadlines and opportunities, ultimately fostering better enrollment and retention outcomes. Additionally, Signal Vine provides customer support services to assist users in maximizing the effectiveness of their messaging strategies.

Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.

InCarda Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cardiovascular diseases. Founded in 2009 and based in Newark, California, the company specializes in a novel inhaled treatment approach to manage acute cardiovascular conditions. Its lead product, InRhythm, is an inhaled formulation of an antiarrhythmic drug designed to treat paroxysmal atrial fibrillation quickly, allowing patients to administer the therapy in various settings, such as at home or work. By delivering medication directly to cardiac tissue, InCarda's therapy aims to provide effective treatment for atrial arrhythmias with a simplified approach. The company has completed Phase 1 clinical trials and is currently advancing its lead product through Phase 2 trials.

Properly, Inc. is a technology company based in San Francisco, California, established in 2014. It offers a platform and mobile application designed to streamline operations related to vacation rental properties, including housekeeping and property maintenance. Properly serves a diverse clientele, including property owners, property managers, and service providers. The company's visual checklist tool facilitates effective communication between property owners and cleaning professionals, ensuring that turnover instructions are easily shared and understood. Properly aims to standardize the cleaning process for hosts and property managers while enhancing the recognition of professional cleaners for their quality work.

Aegis Surgical Limited will facilitate less invasive placement of aortic valves compared to open heart surgery, on an out-patient basis.

3T Biosciences, Inc. is an immunotherapy company founded in 2017 and headquartered in Menlo Park, California. The company focuses on developing innovative drugs and medical research facilities aimed at offering cures for cancer-related diseases. By leveraging synthetic biology and machine learning, 3T Biosciences seeks to discover novel targets for treating cancer and other T-cell-mediated diseases, thereby enhancing treatment options available to healthcare providers and improving patient outcomes.

Huiseoul is an e-commerce company based in Seoul, South Korea, specializing in the online retail of cosmetic products. It focuses on providing personalized skincare consultations and exclusively offers Korean beauty products to the Chinese market. The company has developed a comprehensive online platform that facilitates conversational e-commerce, where beauty consultants deliver detailed skincare advice in a user-friendly format. This platform includes various technological components such as front-end and back-end development, API integration, and mobile applications, all aimed at enhancing the customer experience in skincare shopping.

Freenome, Inc. is an artificial intelligence genomics biotech company based in South San Francisco, California, founded in 2014. The company focuses on developing accurate, accessible, and non-invasive blood tests for the early detection of cancer and treatment selection. Utilizing a proprietary multi-omics platform, Freenome employs advanced algorithms to analyze cell-free genomic data, which aids in identifying early-stage cancers and other diseases. This innovative approach aims to transform disease management by enabling timely interventions and proactive treatment strategies. In addition to its diagnostic solutions, Freenome also offers clinical research services to further advance cancer detection and management.

Signal Vine, Inc. is a technology company that specializes in developing an enterprise text messaging platform designed to enhance communication within educational and nonprofit sectors. Founded in 2013 and headquartered in Alexandria, Virginia, the company offers a range of features including targeted messaging, an intuitive interface, case management, and comprehensive reporting and analytics. By utilizing a blended messaging approach, Signal Vine enables its clients—such as K-12 schools, higher education institutions, nonprofits, and government programs—to leverage student data to deliver personalized communications. This capability aims to improve student engagement by sending timely reminders and support messages about important deadlines and opportunities, ultimately fostering better enrollment and retention outcomes. Additionally, Signal Vine provides customer support services to assist users in maximizing the effectiveness of their messaging strategies.

Indi Molecular, Inc. is a life sciences company based in Culver City, California, established in 2013 as a spinout from Integrated Diagnostics. The company specializes in developing a synthetic class of diagnostic and therapeutic agents known as protein-catalyzed capture (PCC) agents. These agents possess antibody-like properties and are created through a collaborative process with the California Institute of Technology, utilizing a technique called click chemistry, which allows for precise and stable molecular assembly. PCCs are designed to offer improved selectivity and binding affinity compared to traditional monoclonal antibodies, along with a significantly lower molecular weight. This innovative approach enables PCCs to function both as precision-targeted therapeutics and as agents for in vivo PET imaging, utilizing a shared chelation chemistry platform to optimize their application in healthcare settings.

UniKey Technologies, Inc. is a provider of innovative access control solutions, specializing in smart locking technologies for residential, commercial, and hospitality applications. Founded in 2010 and headquartered in Winter Park, Florida, the company transforms smartphones into universal electronic keys, allowing users to unlock doors with a simple touch while keeping their devices in pockets or purses. UniKey's patented technology includes features that can assess whether an authorized user is inside or outside a property before granting access, enhancing security and preventing unauthorized entry. The company collaborates with prominent lock manufacturers like Kwikset and Weiser to develop smart locks, notably the Kevo system, and offers a cloud-based lock management solution tailored for multifamily properties and commercial businesses. By delivering advanced smart lock and access control technologies, UniKey addresses a wide range of security needs.

Amygdala Neurosciences, Inc. is a biopharmaceutical company based in Palo Alto, California, dedicated to discovering, developing, and commercializing pharmacotherapies aimed at treating and preventing addiction. Incorporated in 2015, the company is focused on its lead product, ANS-6637, a selective and reversible aldehyde dehydrogenase 2 (ALDH2) inhibitor. This innovative compound is designed to prevent pathophysiologic dopamine surges that typically contribute to drug-seeking behavior, cravings, and relapse, without affecting baseline dopamine levels. Pre-clinical studies have shown that ANS-6637 effectively reduces self-administration and relapse in various models of substance use, including nicotine, alcohol, cocaine, heroin, and methamphetamine, and also exhibits anxiolytic properties. Having completed extensive Phase 1 studies, Amygdala Neurosciences is poised to initiate Phase 2 efficacy studies, with an initial focus on smoking cessation alongside parallel development for cocaine, opioid, and alcohol use disorders.

Thunder is a technology company that focuses on streamlining the advertising process through its Creative Management Platform. This platform enables advertisers to efficiently create, scale, and manage ad creatives across multiple devices and formats, including display, video, and native ads. By reducing creative friction, Thunder allows brands, media companies, and agencies to produce advertisements more rapidly and effectively. The platform features a user-friendly interface that caters to a range of users, from general marketers to advanced designers, providing tools for testing and targeting creatives to specific audiences across various channels. Thunder serves over 100 notable clients, including InterContinental Hotels Group, Time Warner Cable, Charter Communications, and Hearst, enhancing their advertising capabilities and reach.

Twist Bioscience Corporation is a synthetic biology company that specializes in the manufacture and sale of synthetic DNA-based products. Founded in 2013 and headquartered in South San Francisco, California, the company utilizes a proprietary semiconductor-based DNA synthesis platform that writes DNA on silicon chips, allowing for the rapid and cost-effective production of high-quality synthetic DNA. Twist Bioscience's offerings include synthetic genes, tools for sample preparation, antibody libraries for drug discovery, and DNA as a medium for digital data storage. The company serves various sectors, including healthcare, agriculture, and industrial chemicals, supporting customers in their efforts to enhance lives and promote sustainability. Through its innovative platform, Twist Bioscience aims to overcome traditional inefficiencies in DNA synthesis, enabling researchers to accelerate their projects.

Freenome, Inc. is an artificial intelligence genomics biotech company based in South San Francisco, California, founded in 2014. The company focuses on developing accurate, accessible, and non-invasive blood tests for the early detection of cancer and treatment selection. Utilizing a proprietary multi-omics platform, Freenome employs advanced algorithms to analyze cell-free genomic data, which aids in identifying early-stage cancers and other diseases. This innovative approach aims to transform disease management by enabling timely interventions and proactive treatment strategies. In addition to its diagnostic solutions, Freenome also offers clinical research services to further advance cancer detection and management.

Welkin Health, Inc. is a San Francisco-based company that develops and operates a cloud-based patient management software platform. Founded in 2013, the platform is designed to enhance care delivery by guiding healthcare teams through workflows that ensure patients receive timely and appropriate care. It allows health workers to focus on patients who need attention at critical moments, fostering meaningful relationships between providers and patients. The software is customizable and scalable, supporting a wide range of care programs, including those for chronic diseases and various specialties such as mental health, substance abuse, and oncology. Welkin Health also facilitates communication between health plans, providers, and patients through multiple channels, including phone, text, video, and email, thereby enabling more effective engagement and streamlined care processes.

3T Biosciences, Inc. is an immunotherapy company founded in 2017 and headquartered in Menlo Park, California. The company focuses on developing innovative drugs and medical research facilities aimed at offering cures for cancer-related diseases. By leveraging synthetic biology and machine learning, 3T Biosciences seeks to discover novel targets for treating cancer and other T-cell-mediated diseases, thereby enhancing treatment options available to healthcare providers and improving patient outcomes.

Womply is a local commerce platform founded in 2011 that aims to support the growth of small businesses in a digital environment. The company offers a range of applications, APIs, and marketing and financial tools designed to enhance local commerce for over 500,000 businesses across the United States. Womply's services are driven by its proprietary Womply Commerce Graph, a comprehensive data asset that provides insights into local commerce dynamics. The platform includes features for online presence and reputation management, as well as customer and revenue analytics, addressing the typical needs of local businesses. Through its technology and data-driven approach, Womply seeks to empower small businesses to thrive and simplify their operational challenges.

Mozio, Inc. is an online airport transportation search and booking engine based in San Francisco, California, founded in 2012. The company's platform enables travelers to easily search and book a variety of transportation options, including shared ride shuttles, private vans, taxis, limousines, and SUVs, across multiple regions, including the United States, Canada, Latin America, Europe, and Asia. Designed to simplify the travel experience, Mozio aggregates local transportation services, helping users navigate their options and secure the best deals for their airport transfers. Additionally, Mozio offers API and affiliate programs, allowing travel websites and agents to sell various transportation services, thereby enhancing customer loyalty and monetization opportunities for travel brands.

InCarda Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cardiovascular diseases. Founded in 2009 and based in Newark, California, the company specializes in a novel inhaled treatment approach to manage acute cardiovascular conditions. Its lead product, InRhythm, is an inhaled formulation of an antiarrhythmic drug designed to treat paroxysmal atrial fibrillation quickly, allowing patients to administer the therapy in various settings, such as at home or work. By delivering medication directly to cardiac tissue, InCarda's therapy aims to provide effective treatment for atrial arrhythmias with a simplified approach. The company has completed Phase 1 clinical trials and is currently advancing its lead product through Phase 2 trials.

Evidation Health, Inc. is a California-based company that specializes in developing digital tools and technologies for healthcare data analytics. Founded in 2012, the company connects digital health firms with healthcare providers, payers, and other stakeholders through its advanced technology solutions. Its primary offerings include a data platform that transforms everyday behavior data from various sources, such as sensors and devices, into meaningful health insights, and a technology-enabled service called Studies that facilitates real-world research using this data. Evidation Health aims to enhance the understanding of how daily behaviors impact health and disease, ultimately empowering individuals to engage in better health outcomes. The company's commitment to user privacy and control over health data has garnered trust from millions of individuals, enabling them to participate in innovative health programs and research.

ViewPoint Therapeutics, founded in 2014 and headquartered in San Francisco, specializes in developing treatments for diseases caused by protein misfolding. Its primary focus is on age-related cataracts, a leading cause of blindness worldwide. The company's innovative approach involves creating crystallin stabilizers, including a small molecule active in preclinical models of cataracts. These stabilizers aim to prevent or reverse protein misfolding, which underlies various common disorders associated with aging. ViewPoint Therapeutics is committed to advancing its pipeline to deliver effective therapies for these conditions.

Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.

SensOmics is a company that develops advanced medical wearable technology aimed at the early detection of pediatric diseases. Its innovative approach focuses on genomics for the early-stage detection of conditions such as autism. By integrating genomics with clinical informatics, electrical engineering, and artificial intelligence, SensOmics enables healthcare professionals to diagnose these diseases more effectively and provide timely treatments, ultimately enhancing recovery outcomes for children.

Aegis Surgical Limited will facilitate less invasive placement of aortic valves compared to open heart surgery, on an out-patient basis.

RallyPoint Networks, Inc. is an online networking platform dedicated to serving current and former U.S. military members, as well as their civilian supporters. Founded in 2012 and based in Watertown, Massachusetts, RallyPoint facilitates connections among its two million users, enabling them to build professional networks and explore career opportunities both within the military and in the private sector. The platform assists members in translating their military experiences for civilian employers, effectively bridging the gap between transitioning veterans and organizations seeking their skills. RallyPoint aims to support the military community in leading successful and fulfilling lives while providing employers with targeted tools to engage with this unique talent pool. The company operates as a subsidiary of Student Veterans of America.

WellDoc, Inc. is a healthcare technology company focused on chronic disease management, particularly diabetes. Founded in 2005 and headquartered in Baltimore, Maryland, with additional offices in Wilmington, Delaware, and Bengaluru, India, WellDoc develops innovative solutions that integrate into existing healthcare workflows. Its flagship platform, DiabetesManager, provides personalized, real-time coaching and support for patients and healthcare providers, facilitating self-management and adherence to treatment regimens. The platform features tools for medication reminders, alerts for out-of-range metrics, and cloud-based analytics for tracking health outcomes. Additionally, WellDoc offers BlueStar, a mobile prescription therapy solution that guides patients in managing their diabetes. The company serves various stakeholders in the healthcare ecosystem, including payors, employers, pharmaceutical companies, and medical device firms, and has established strategic partnerships to enhance its offerings.

Profusa, Inc. is a digital health technology company based in Emeryville, California, specializing in the design and development of tissue-integrated sensors and biosensors aimed at improving diabetes management. Founded in 2009, the company focuses on creating biointegrated sensors that allow individuals to monitor their biochemical data in real-time, facilitating better management of personal health and chronic diseases. Profusa's technology aims to seamlessly integrate with the body, providing continuous, clinical-grade data that enhances health outcomes. In addition to its sensor technology, the company has developed software that offers biofeedback to support chronic disease management and promote healthy living.

Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.

Thunder is a technology company that focuses on streamlining the advertising process through its Creative Management Platform. This platform enables advertisers to efficiently create, scale, and manage ad creatives across multiple devices and formats, including display, video, and native ads. By reducing creative friction, Thunder allows brands, media companies, and agencies to produce advertisements more rapidly and effectively. The platform features a user-friendly interface that caters to a range of users, from general marketers to advanced designers, providing tools for testing and targeting creatives to specific audiences across various channels. Thunder serves over 100 notable clients, including InterContinental Hotels Group, Time Warner Cable, Charter Communications, and Hearst, enhancing their advertising capabilities and reach.

Welkin Health, Inc. is a San Francisco-based company that develops and operates a cloud-based patient management software platform. Founded in 2013, the platform is designed to enhance care delivery by guiding healthcare teams through workflows that ensure patients receive timely and appropriate care. It allows health workers to focus on patients who need attention at critical moments, fostering meaningful relationships between providers and patients. The software is customizable and scalable, supporting a wide range of care programs, including those for chronic diseases and various specialties such as mental health, substance abuse, and oncology. Welkin Health also facilitates communication between health plans, providers, and patients through multiple channels, including phone, text, video, and email, thereby enabling more effective engagement and streamlined care processes.

Twist Bioscience Corporation is a synthetic biology company that specializes in the manufacture and sale of synthetic DNA-based products. Founded in 2013 and headquartered in South San Francisco, California, the company utilizes a proprietary semiconductor-based DNA synthesis platform that writes DNA on silicon chips, allowing for the rapid and cost-effective production of high-quality synthetic DNA. Twist Bioscience's offerings include synthetic genes, tools for sample preparation, antibody libraries for drug discovery, and DNA as a medium for digital data storage. The company serves various sectors, including healthcare, agriculture, and industrial chemicals, supporting customers in their efforts to enhance lives and promote sustainability. Through its innovative platform, Twist Bioscience aims to overcome traditional inefficiencies in DNA synthesis, enabling researchers to accelerate their projects.

Thunder is a technology company that focuses on streamlining the advertising process through its Creative Management Platform. This platform enables advertisers to efficiently create, scale, and manage ad creatives across multiple devices and formats, including display, video, and native ads. By reducing creative friction, Thunder allows brands, media companies, and agencies to produce advertisements more rapidly and effectively. The platform features a user-friendly interface that caters to a range of users, from general marketers to advanced designers, providing tools for testing and targeting creatives to specific audiences across various channels. Thunder serves over 100 notable clients, including InterContinental Hotels Group, Time Warner Cable, Charter Communications, and Hearst, enhancing their advertising capabilities and reach.

Aegis Surgical Limited will facilitate less invasive placement of aortic valves compared to open heart surgery, on an out-patient basis.

Amygdala Neurosciences, Inc. is a biopharmaceutical company based in Palo Alto, California, dedicated to discovering, developing, and commercializing pharmacotherapies aimed at treating and preventing addiction. Incorporated in 2015, the company is focused on its lead product, ANS-6637, a selective and reversible aldehyde dehydrogenase 2 (ALDH2) inhibitor. This innovative compound is designed to prevent pathophysiologic dopamine surges that typically contribute to drug-seeking behavior, cravings, and relapse, without affecting baseline dopamine levels. Pre-clinical studies have shown that ANS-6637 effectively reduces self-administration and relapse in various models of substance use, including nicotine, alcohol, cocaine, heroin, and methamphetamine, and also exhibits anxiolytic properties. Having completed extensive Phase 1 studies, Amygdala Neurosciences is poised to initiate Phase 2 efficacy studies, with an initial focus on smoking cessation alongside parallel development for cocaine, opioid, and alcohol use disorders.

Evidation Health, Inc. is a California-based company that specializes in developing digital tools and technologies for healthcare data analytics. Founded in 2012, the company connects digital health firms with healthcare providers, payers, and other stakeholders through its advanced technology solutions. Its primary offerings include a data platform that transforms everyday behavior data from various sources, such as sensors and devices, into meaningful health insights, and a technology-enabled service called Studies that facilitates real-world research using this data. Evidation Health aims to enhance the understanding of how daily behaviors impact health and disease, ultimately empowering individuals to engage in better health outcomes. The company's commitment to user privacy and control over health data has garnered trust from millions of individuals, enabling them to participate in innovative health programs and research.

CardioGen Sciences is a biotechnology company that develops and offers gene therapy solutions for orphan-inherited arrhythmogenic diseases. It was founded in 2014 and is based in Palo Alto, California.

Womply is a local commerce platform founded in 2011 that aims to support the growth of small businesses in a digital environment. The company offers a range of applications, APIs, and marketing and financial tools designed to enhance local commerce for over 500,000 businesses across the United States. Womply's services are driven by its proprietary Womply Commerce Graph, a comprehensive data asset that provides insights into local commerce dynamics. The platform includes features for online presence and reputation management, as well as customer and revenue analytics, addressing the typical needs of local businesses. Through its technology and data-driven approach, Womply seeks to empower small businesses to thrive and simplify their operational challenges.

LiquidM Technology, established in 2013, is a Berlin-based company that operates as a subsidiary of Smart AdServer SAS. It specializes in providing a single, intuitive platform for advertising and campaign management, primarily focused on mobile display media. The company's modular, cloud-based software enables agencies and trading desks to customize their ad tech infrastructure, offering greater efficiency, control, and insights into media planning and buying. LiquidM's platform is white-labeled, agnostic to third-party integrations, and supports real-time bidding, targeting, and inventory procurement.

CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, specializing in cardiovascular genomic diagnostics. Founded in 2003, the company develops clinically validated tests aimed at improving the assessment and management of cardiovascular diseases, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure. One of its key products is the Corus CAD test, a blood-based gene expression test designed to help primary care clinicians and cardiologists determine whether a non-diabetic patient's chest discomfort or other symptoms are indicative of obstructive CAD. By utilizing genomic technologies, CardioDx provides healthcare professionals with actionable information to enhance treatment decisions and patient outcomes while potentially reducing healthcare costs. The company primarily serves customers in the United States.

Signal Vine, Inc. is a technology company that specializes in developing an enterprise text messaging platform designed to enhance communication within educational and nonprofit sectors. Founded in 2013 and headquartered in Alexandria, Virginia, the company offers a range of features including targeted messaging, an intuitive interface, case management, and comprehensive reporting and analytics. By utilizing a blended messaging approach, Signal Vine enables its clients—such as K-12 schools, higher education institutions, nonprofits, and government programs—to leverage student data to deliver personalized communications. This capability aims to improve student engagement by sending timely reminders and support messages about important deadlines and opportunities, ultimately fostering better enrollment and retention outcomes. Additionally, Signal Vine provides customer support services to assist users in maximizing the effectiveness of their messaging strategies.

Biomimedica is a medical device company based in South San Francisco, California, dedicated to innovating joint repair solutions through its proprietary synthetic cartilage technology. Founded in 2007, the company specializes in developing synthetic cartilages designed to restore the surface of damaged joints, providing effective medical devices for joint repair. Its pioneering approaches aim to enhance patient outcomes and advance the field of orthopedic medicine.

Benefitter Insurance Solutions, Inc. is a company that provides web-based tools designed to assist employers in managing employee health coverage. Incorporated in 2012 and based in San Francisco, California, it offers a range of solutions including ReformCommunicator, which generates required communications regarding healthcare options; ReformNavigator, which assists employees in selecting and enrolling in health insurance; ReformAdvisor, which helps determine the suitability of employer-sponsored coverage; and ReformReadiness, which gathers necessary data for employee census and insurance quoting. By enhancing the decision-making process for both employers and employees, Benefitter aims to simplify navigation through health care reform and improve overall employee well-being. As of August 2015, the company operates as a subsidiary of HealthMarkets Insurance Company.

Twist Bioscience Corporation is a synthetic biology company that specializes in the manufacture and sale of synthetic DNA-based products. Founded in 2013 and headquartered in South San Francisco, California, the company utilizes a proprietary semiconductor-based DNA synthesis platform that writes DNA on silicon chips, allowing for the rapid and cost-effective production of high-quality synthetic DNA. Twist Bioscience's offerings include synthetic genes, tools for sample preparation, antibody libraries for drug discovery, and DNA as a medium for digital data storage. The company serves various sectors, including healthcare, agriculture, and industrial chemicals, supporting customers in their efforts to enhance lives and promote sustainability. Through its innovative platform, Twist Bioscience aims to overcome traditional inefficiencies in DNA synthesis, enabling researchers to accelerate their projects.

Reify Health, Inc. is a Baltimore-based company that specializes in cloud-based software aimed at enhancing the development of new therapies within the life sciences sector. Founded in 2010, Reify Health provides solutions designed to streamline clinical research processes, particularly in the area of patient enrollment for clinical trials. Its flagship product, StudyTeam, allows research sponsors, contract research organizations, and clinical sites to achieve faster and more predictable enrollment outcomes. By automating and simplifying the enrollment process, Reify Health's software enables teams to concentrate on essential tasks that drive research success, thereby improving overall productivity and optimizing study budgets.

Aegis Surgical Limited will facilitate less invasive placement of aortic valves compared to open heart surgery, on an out-patient basis.

Twist Bioscience Corporation is a synthetic biology company that specializes in the manufacture and sale of synthetic DNA-based products. Founded in 2013 and headquartered in South San Francisco, California, the company utilizes a proprietary semiconductor-based DNA synthesis platform that writes DNA on silicon chips, allowing for the rapid and cost-effective production of high-quality synthetic DNA. Twist Bioscience's offerings include synthetic genes, tools for sample preparation, antibody libraries for drug discovery, and DNA as a medium for digital data storage. The company serves various sectors, including healthcare, agriculture, and industrial chemicals, supporting customers in their efforts to enhance lives and promote sustainability. Through its innovative platform, Twist Bioscience aims to overcome traditional inefficiencies in DNA synthesis, enabling researchers to accelerate their projects.

Maverix Biomics, Inc. is a biotechnology company based in San Mateo, California, that offers a cloud-based platform tailored for biologists and life science researchers. Founded in 2010, the platform facilitates the management, analysis, and visualization of genomic data, addressing the needs of researchers in various domains, including RNA-seq, ChIP-seq, and methylation analysis. By integrating genomic data with biomic information across viral, bacterial, vertebrate, and plant genomes, Maverix Biomics aims to enhance research capabilities and foster collaborative discovery. The company leverages expertise from leading research institutions and technology firms, creating an open platform that combines advanced bioinformatics with user-friendly features to streamline complex data analytics. This approach not only accelerates scientific advancements but also helps overcome traditional research bottlenecks.

Womply is a local commerce platform founded in 2011 that aims to support the growth of small businesses in a digital environment. The company offers a range of applications, APIs, and marketing and financial tools designed to enhance local commerce for over 500,000 businesses across the United States. Womply's services are driven by its proprietary Womply Commerce Graph, a comprehensive data asset that provides insights into local commerce dynamics. The platform includes features for online presence and reputation management, as well as customer and revenue analytics, addressing the typical needs of local businesses. Through its technology and data-driven approach, Womply seeks to empower small businesses to thrive and simplify their operational challenges.

Indi Molecular, Inc. is a life sciences company based in Culver City, California, established in 2013 as a spinout from Integrated Diagnostics. The company specializes in developing a synthetic class of diagnostic and therapeutic agents known as protein-catalyzed capture (PCC) agents. These agents possess antibody-like properties and are created through a collaborative process with the California Institute of Technology, utilizing a technique called click chemistry, which allows for precise and stable molecular assembly. PCCs are designed to offer improved selectivity and binding affinity compared to traditional monoclonal antibodies, along with a significantly lower molecular weight. This innovative approach enables PCCs to function both as precision-targeted therapeutics and as agents for in vivo PET imaging, utilizing a shared chelation chemistry platform to optimize their application in healthcare settings.

RallyPoint Networks, Inc. is an online networking platform dedicated to serving current and former U.S. military members, as well as their civilian supporters. Founded in 2012 and based in Watertown, Massachusetts, RallyPoint facilitates connections among its two million users, enabling them to build professional networks and explore career opportunities both within the military and in the private sector. The platform assists members in translating their military experiences for civilian employers, effectively bridging the gap between transitioning veterans and organizations seeking their skills. RallyPoint aims to support the military community in leading successful and fulfilling lives while providing employers with targeted tools to engage with this unique talent pool. The company operates as a subsidiary of Student Veterans of America.

LiquidM Technology, established in 2013, is a Berlin-based company that operates as a subsidiary of Smart AdServer SAS. It specializes in providing a single, intuitive platform for advertising and campaign management, primarily focused on mobile display media. The company's modular, cloud-based software enables agencies and trading desks to customize their ad tech infrastructure, offering greater efficiency, control, and insights into media planning and buying. LiquidM's platform is white-labeled, agnostic to third-party integrations, and supports real-time bidding, targeting, and inventory procurement.

Lark is a developer of a virtual platform focused on chronic disease prevention and management. Founded in 2011 by Julia Hu and Jeff Zira, the company is headquartered in Mountain View, California. Lark's platform leverages advanced artificial intelligence alongside human coaching and connected devices to offer real-time, personalized support and counseling. This approach aims to help users make healthier choices and effectively manage their chronic conditions. The company's programs, including those recognized by the CDC for diabetes prevention, wellness, diabetes care, and hypertension, serve approximately 1.5 million users. These initiatives have shown clinically validated improvements in health outcomes, as documented in multiple peer-reviewed journals and analyst reports.

Profusa, Inc. is a digital health technology company based in Emeryville, California, specializing in the design and development of tissue-integrated sensors and biosensors aimed at improving diabetes management. Founded in 2009, the company focuses on creating biointegrated sensors that allow individuals to monitor their biochemical data in real-time, facilitating better management of personal health and chronic diseases. Profusa's technology aims to seamlessly integrate with the body, providing continuous, clinical-grade data that enhances health outcomes. In addition to its sensor technology, the company has developed software that offers biofeedback to support chronic disease management and promote healthy living.

Keepsafe Software Inc. is a company that specializes in digital privacy solutions, providing applications designed to protect personal content on mobile devices. Founded in 2012 and based in San Francisco, California, Keepsafe offers a suite of apps, including Keepsafe Photos, Keepsafe Documents, and AppLock, which allow users to secure and manage their private photos, videos, and documents. The software is available for both iOS and Android platforms and is designed to prevent unauthorized access to sensitive data, enabling users to maintain ownership over their digital privacy while providing options for safe sharing. Keepsafe aims to simplify the management of personal information in the digital realm, making privacy as straightforward as it is in the physical world.

Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.

Evidation Health, Inc. is a California-based company that specializes in developing digital tools and technologies for healthcare data analytics. Founded in 2012, the company connects digital health firms with healthcare providers, payers, and other stakeholders through its advanced technology solutions. Its primary offerings include a data platform that transforms everyday behavior data from various sources, such as sensors and devices, into meaningful health insights, and a technology-enabled service called Studies that facilitates real-world research using this data. Evidation Health aims to enhance the understanding of how daily behaviors impact health and disease, ultimately empowering individuals to engage in better health outcomes. The company's commitment to user privacy and control over health data has garnered trust from millions of individuals, enabling them to participate in innovative health programs and research.

Synecor LLC is a medical device company based in Durham, North Carolina, with additional locations in California and North Carolina. Founded in 2000 by Dr. Richard Stack, the company emerged from collaborative relationships in the field of interventional cardiology. Synecor specializes in developing innovative medical device technologies across various specialties, including obesity and spine therapeutics. The company focuses on creating minimally invasive device-based treatments, bioerodible vascular stent platforms for coronary artery disease, and solutions for managing arrhythmias. Additionally, Synecor is advancing a technology platform designed to access and treat the gastrointestinal system through natural orifices. By addressing unmet medical needs, Synecor aims to offer effective treatment options that enable patients to begin their care promptly, thereby improving the likelihood of successful outcomes.

HealthTap is a virtual-first healthcare provider that delivers affordable urgent and primary care services to all Americans, regardless of insurance status. The company aims to ensure equitable access to quality physician care across the nation. HealthTap's platform allows users to connect with doctors through various means, including limited texting, video appointments, and urgent care consultations with the next available physician. Additionally, the service offers free responses to health inquiries from a network of volunteer doctors across different specialties, empowering users to select and maintain a long-term primary care physician for their ongoing health needs.

Proteus Digital Health, Inc. was a digital medicines company headquartered in Redwood City, California, founded in 2001. It specialized in developing innovative products and services that integrated pharmaceuticals with ingestible sensors, wearable technology, mobile applications, and cloud computing. The company's offerings included ingestible sensors that communicated medication adherence, wearable sensor patches to monitor physiological responses, and digital platforms for data analytics. These technologies aimed to empower patients and their families in managing health, while providing healthcare providers with tools to enhance decision-making and optimize treatment outcomes. In November 2020, Proteus Digital Health filed for Chapter 11 bankruptcy and subsequently ceased operations.

Esperion discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases. Esperion intends to commercialize a novel class of drugs that focuses on a new treatment approach called "HDL Therapy," which is based on the Company's understanding of high-density lipoprotein, or HDL, function.

Reify Health, Inc. is a Baltimore-based company that specializes in cloud-based software aimed at enhancing the development of new therapies within the life sciences sector. Founded in 2010, Reify Health provides solutions designed to streamline clinical research processes, particularly in the area of patient enrollment for clinical trials. Its flagship product, StudyTeam, allows research sponsors, contract research organizations, and clinical sites to achieve faster and more predictable enrollment outcomes. By automating and simplifying the enrollment process, Reify Health's software enables teams to concentrate on essential tasks that drive research success, thereby improving overall productivity and optimizing study budgets.

Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.

CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, specializing in cardiovascular genomic diagnostics. Founded in 2003, the company develops clinically validated tests aimed at improving the assessment and management of cardiovascular diseases, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure. One of its key products is the Corus CAD test, a blood-based gene expression test designed to help primary care clinicians and cardiologists determine whether a non-diabetic patient's chest discomfort or other symptoms are indicative of obstructive CAD. By utilizing genomic technologies, CardioDx provides healthcare professionals with actionable information to enhance treatment decisions and patient outcomes while potentially reducing healthcare costs. The company primarily serves customers in the United States.

Biomimedica is a medical device company based in South San Francisco, California, dedicated to innovating joint repair solutions through its proprietary synthetic cartilage technology. Founded in 2007, the company specializes in developing synthetic cartilages designed to restore the surface of damaged joints, providing effective medical devices for joint repair. Its pioneering approaches aim to enhance patient outcomes and advance the field of orthopedic medicine.

Reify Health, Inc. is a Baltimore-based company that specializes in cloud-based software aimed at enhancing the development of new therapies within the life sciences sector. Founded in 2010, Reify Health provides solutions designed to streamline clinical research processes, particularly in the area of patient enrollment for clinical trials. Its flagship product, StudyTeam, allows research sponsors, contract research organizations, and clinical sites to achieve faster and more predictable enrollment outcomes. By automating and simplifying the enrollment process, Reify Health's software enables teams to concentrate on essential tasks that drive research success, thereby improving overall productivity and optimizing study budgets.

Terra Bella is a private company based in Mountain View, California, specializing in high-resolution satellite imagery and analytics services. Originally founded as Skybox Imaging in 2009 by Dan Berkenstock, Julian Mann, John Fenwick, and Ching-Yu Hu, the company operates the SkySat-1 satellite, which captures detailed panchromatic and multispectral images of the Earth. Terra Bella focuses on analyzing the movement of goods and people, providing valuable visual data for various applications, including supply chain monitoring, shipping logistics, industrial plant activity, and humanitarian relief efforts. Through its advanced imaging technology, the company aims to deliver critical insights that support decision-making across multiple sectors.

Keepsafe Software Inc. is a company that specializes in digital privacy solutions, providing applications designed to protect personal content on mobile devices. Founded in 2012 and based in San Francisco, California, Keepsafe offers a suite of apps, including Keepsafe Photos, Keepsafe Documents, and AppLock, which allow users to secure and manage their private photos, videos, and documents. The software is available for both iOS and Android platforms and is designed to prevent unauthorized access to sensitive data, enabling users to maintain ownership over their digital privacy while providing options for safe sharing. Keepsafe aims to simplify the management of personal information in the digital realm, making privacy as straightforward as it is in the physical world.

HealthTap is a virtual-first healthcare provider that delivers affordable urgent and primary care services to all Americans, regardless of insurance status. The company aims to ensure equitable access to quality physician care across the nation. HealthTap's platform allows users to connect with doctors through various means, including limited texting, video appointments, and urgent care consultations with the next available physician. Additionally, the service offers free responses to health inquiries from a network of volunteer doctors across different specialties, empowering users to select and maintain a long-term primary care physician for their ongoing health needs.

ICON Aircraft, Inc. is a manufacturer based in Vacaville, California, that specializes in designing, developing, and producing light consumer sport aircraft. Founded in 2004, the company aims to make personal flight more accessible through innovative and safe aircraft, including its flagship model, the A5. The A5 is an amphibious sport plane recognized for its advanced aeronautical engineering, unique design, and safety features, including being the world's first production aircraft that is spin-resistant. ICON Aircraft also operates an online store selling various aviation-related gear and apparel. The company's mission is to democratize personal flight and 3-D mobility, fostering a culture that encourages intelligent risk-taking and collaboration among its team members. With a commitment to delivering technologically advanced and consumer-friendly products, ICON Aircraft seeks to inspire a global community of aviation enthusiasts.

HealthTap is a virtual-first healthcare provider that delivers affordable urgent and primary care services to all Americans, regardless of insurance status. The company aims to ensure equitable access to quality physician care across the nation. HealthTap's platform allows users to connect with doctors through various means, including limited texting, video appointments, and urgent care consultations with the next available physician. Additionally, the service offers free responses to health inquiries from a network of volunteer doctors across different specialties, empowering users to select and maintain a long-term primary care physician for their ongoing health needs.

ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company specializing in the development of immune-based therapies for various cancers. The company is known for its innovative products, including ICT-107, a dendritic cell immunotherapy designed for newly diagnosed glioblastoma multiforme, a highly aggressive brain cancer. Additionally, ImmunoCellular is advancing ICT-140, which targets tumor-associated antigens in ovarian cancer, and ICT-121, aimed at treating recurrent glioblastoma and other solid tumors by targeting CD133 markers on cancer stem cells. The company also explores Steam-to-T-Cell immunotherapies to enhance cancer treatment. ImmunoCellular Therapeutics has established licensing agreements with prestigious institutions such as the California Institute of Technology and The Johns Hopkins University. Originally named Optical Molecular Imaging, Inc., the company rebranded in November 2006 and is headquartered in Westlake Village, California.

Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, focused on the development of innovative medicines for patients with cancer and serious viral infections. The company is advancing several clinical-stage programs, including dociparstat sodium (DSTAT), a glycosaminoglycan compound aimed at improving outcomes for patients with acute myeloid leukemia during chemotherapy. Another key candidate is brincidofovir (BCV), an antiviral drug being developed as a medical countermeasure for smallpox. Chimerix also leads the development of CMX001, a broad-spectrum antiviral agent targeting life-threatening double-stranded DNA viral infections, currently undergoing multiple clinical studies for use in immunocompromised patients. Additionally, CMX157, an antiviral compound with activity against HIV and hepatitis B, is in development, addressing challenges posed by existing therapies. The company collaborates with various organizations for research and commercialization, deriving revenue from licensing agreements and royalties. Founded in 2000, Chimerix is committed to transforming patient care through its advanced therapeutic candidates.

Ooma, Inc. is a communications services company that specializes in creating connected experiences for both businesses and consumers. Headquartered in Sunnyvale, California, Ooma offers a smart cloud-based software-as-a-service (SaaS) platform that provides a range of communication solutions. For businesses, Ooma delivers advanced voice and collaboration features through its offerings, such as Ooma Office and Ooma Enterprise, which include services like call recording, voicemail transcription, and mobile integration. For residential customers, Ooma provides home communications solutions like Ooma Telo, which serves as a primary phone line with high-definition voice quality and smart security features. The company also offers a variety of products, including mobile apps and security solutions, allowing users to monitor and control their home environments. Ooma generates revenue primarily through subscription services, distributing its products through direct sales, retailers, and online channels. Established in 2003, Ooma continues to innovate in the realm of connected communications and security.

Rapidscan Pharma Solutions, Inc. is a pharmaceutical company founded in 2010, specializing in the development, manufacture, and sale of a pharmacological stress agent known as Regadenoson. This agent is utilized in the diagnosis and risk stratification of cardiovascular disease, particularly for patients undergoing myocardial perfusion imaging procedures. Rapidscan has secured licensing rights to market Regadenoson across various regions, including Europe, Latin America, Japan, Australia, New Zealand, and Israel. With a significant patient population affected by coronary artery disease, the company addresses a critical need in cardiovascular diagnostics. Rapidscan operates as a subsidiary of GE Healthcare.

Provade, Inc. is a provider of enterprise vendor management systems focused on workforce management and procurement. Established in 2004 and headquartered in Milwaukee, Wisconsin, with additional offices in Pleasanton, California; Highworth, United Kingdom; and Sydney, Australia, the company serves medium to large enterprises across various sectors, including technology, finance, and manufacturing. Provade specializes in contingent workforce management and offers a suite of services such as identity management, implementation, training, support, and managed services. Its solutions are built around Oracle's enterprise platform, enabling organizations to improve efficiency, gain visibility, and achieve measurable savings in contingent labor and procurement processes. The company also provides subscription-based applications that integrate with existing financial and HR systems, along with professional services to enhance procurement strategies. As of early 2018, Provade operates as a subsidiary of Smart ERP Solutions Inc.

CardioDx, Inc. is a molecular diagnostics company based in Redwood City, California, specializing in cardiovascular genomic diagnostics. Founded in 2003, the company develops clinically validated tests aimed at improving the assessment and management of cardiovascular diseases, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure. One of its key products is the Corus CAD test, a blood-based gene expression test designed to help primary care clinicians and cardiologists determine whether a non-diabetic patient's chest discomfort or other symptoms are indicative of obstructive CAD. By utilizing genomic technologies, CardioDx provides healthcare professionals with actionable information to enhance treatment decisions and patient outcomes while potentially reducing healthcare costs. The company primarily serves customers in the United States.

OfferIQ specializes in providing paperless coupon services, focusing on delivering in-store shopping discounts directly to consumers' mobile phones. The company operates a Virtual Incentive Platform that links incentives to a consumer's debit or credit card, allowing these discounts to be redeemed seamlessly during the payment process. This approach eliminates the need for retailers to make any modifications at the point of sale or provide additional staff training.